BGU researcher, colleagues identify compound that may prolong life for Amytotrophic Lateral Sclerosis patients.
Prof. Esther Priel - Photo By BGU
A Ben-Gurion University researcher and her colleagues have identified a chemical compound that may lead to prolonged lifespans for patients with Amytotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.
Prof. Esther Priel and her team published an article in the February edition of EMBO Molecular Medicine Journal, in which they demonstrate how their compound can induce an increased production of the enzyme telomerase in the bodies of laboratory mice and in human stem cells. The increased amount of telomerase slows the progression of ALS, also known as Lou Gehrig’s disease.
Israeli New Shekel Exchange Rate